Finance

Lists
PBYI:NASDAQ
Puma Biotechnology Inc
$7.05
-0.98%
(-0.070) 1D
$7.05
0.00% (0.00)
After hours
Closed: Nov 20, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PBYI...
Open
$7.05
High
$7.22
Low
$6.91
Mkt. cap
364.47M
Avg. vol.
448.32K
Volume
861.21K
P/E ratio
15.52
52-wk high
$11.50
52-wk low
$4.84
EPS
$0.45
Beta
1.40
Shares outstanding
51.70M
No. of employees
179
Open
$7.05
High
$7.22
Low
$6.91
Mkt. cap
364.47M
Avg. vol.
448.32K
Volume
861.21K
P/E ratio
15.52
52-wk high
$11.50
52-wk low
$4.84
EPS
$0.45
Beta
1.40
Shares outstanding
51.70M
No. of employees
179
News stories
From web sources and news partners
Profile
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA. Wikipedia
About Puma Biotechnology Inc
CEO-
Employees179
Founded2007
HeadquartersLos Angeles, California, United States
SectorHealth Care
IndustryBiotechnology
Analyst
Recommendation
Action
Price target
Projected
Date
Marc Frahm
TD Cowen
Hold
Maintained
$6.00
-14.9%
08/07/2026
Gena Wang
Barclays
Sell
Maintained
$2.00
-71.6%
11/07/2025
Last report
Nov 5, 2026
Fiscal period
Q3 2026
$0.15 / $0.12
+25.00%beat
Revenue / Est. (USD)
55.06M / 57.50M
-4.25%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
75.45M
44.81M
56.50M
55.06M
Cost of goods sold
23.13M
10.42M
12.48M
15.20M
Cost of revenue
23.13M
10.42M
12.48M
15.20M
Research and development expenses
16.84M
19.80M
18.90M
18.28M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.38M
18.42M
17.55M
16.30M
Operating expense
35.22M
38.22M
36.44M
34.58M
Total operating expenses
58.35M
48.64M
48.92M
49.78M
Operating income
17.11M
-3.83M
7.58M
5.27M
Other non operating income
143.00K
130.00K
9.00K
19.00K
EBT including unusual items
17.11M
-3.43M
8.24M
6.17M
EBT excluding unusual items
17.11M
-3.43M
8.24M
6.17M
Income tax expense
3.67M
326.00K
56.00K
216.00K
Effective tax rate
21.45%
-9.51%
0.68%
3.50%
Other operating expenses
-
-
-
-
Net income
13.44M
-3.75M
8.19M
5.96M
Net profit margin
17.81%
-8.37%
14.49%
10.82%
Earnings per share
0.29
-0.04
0.20
-
Interest and investment income
977.00K
1.00M
831.00K
879.00K
Interest expense
-1.12M
-731.00K
-180.00K
-
Net interest expenses
-142.00K
271.00K
651.00K
879.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
18.96M
-1.24M
10.10M
7.73M
Gain or loss from assets sale
4.00K
6.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps